title: Progression of osteoporosis in patients with COPD: a 3-year follow up study.
abstract: Currently, our knowledge on the progression of osteoporosis and its determinants is limited in patients with chronic obstructive pulmonary disease (COPD). Bone mineral density generally remains stable in patients with COPD over a period of 3 years. Nevertheless, the progression of vertebral fractures was not assessed, while an increase of vertebral fractures over time may be reasonable. Aims of the current study were to determine the percentage of newly diagnosed osteoporotic patients after a follow up of 3 years and to identify baseline risk factors for the progression of osteoporosis in COPD. Clinically stable COPD outpatients were included. Lung function parameters, body composition measures, six minute walk distance, DXA-scan and X-spine were assessed at baseline and repeated after 3 years. Prevalence of osteoporosis in COPD patients increased from 47% to 61% in 3 years mostly due to an increase of vertebral fractures. Lower baseline T-score at the trochanter independently increased the risk for the development of osteoporosis. Additionally, baseline vitamin D deficiency increased this risk 7.5-fold. In conclusion, the prevalence of osteoporosis increased over a 3-year period in patients with COPD. Baseline risk factors for the development of osteoporosis are osteopenia at the trochanter and vitamin D deficiency.
authors.affiliation: Department of Respiratory Medicine, Catharina Hospital Eindhoven, Michelangelolaan 2, 5623 GS Eindhoven, The Netherlands. lidwiengraat@versatel.nl
authors.forename: Lidwien
authors.initials: L
authors.lastname: Graat-Verboom
authors.forename: Frank W J M
authors.initials: FW
authors.lastname: Smeenk
authors.forename: Ben E E M
authors.initials: BE
authors.lastname: van den Borne
authors.forename: Martijn A
authors.initials: MA
authors.lastname: Spruit
authors.forename: Frits H
authors.initials: FH
authors.lastname: Jansen
authors.forename: Joris W T
authors.initials: JW
authors.lastname: van Enschot
authors.forename: Emiel F M
authors.initials: EF
authors.lastname: Wouters
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015519:Bone Density / Q000502:physiology; D018450:Disease Progression; D005260:Female; D005269:Femur / Q000503:physiopathology; D005500:Follow-Up Studies; D005541:Forced Expiratory Volume / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000209:etiology* / Q000503:physiopathology; D015663:Osteoporosis, Postmenopausal / Q000209:etiology / Q000503:physiopathology; D058866:Osteoporotic Fractures / Q000209:etiology / Q000503:physiopathology; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications* / Q000503:physiopathology; D012307:Risk Factors; D016103:Spinal Fractures / Q000209:etiology / Q000503:physiopathology; D014808:Vitamin D Deficiency / Q000150:complications